Personalized treatment for anxiety and alcohol use problems
Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Comorbidity and Treatment
This study is testing a personalized treatment combining therapy and digital tools to help people with anxiety and alcohol use problems feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 81 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Piscataway, New Jersey) |
| Trial ID | NCT05821634 on ClinicalTrials.gov |
What this trial studies
This research focuses on individuals with anxiety disorders and alcohol use problems, utilizing digital technology to identify personal risk factors that contribute to these issues. By understanding these factors, the study aims to create a tailored intervention that integrates cognitive behavioral therapy with innovative digital methods. Participants will receive personalized treatment designed to improve their psychological well-being and reduce alcohol-related problems. The study emphasizes the importance of telehealth counseling for individuals seeking help.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who experience significant anxiety or trauma-related symptoms and have alcohol use problems.
Not a fit: Patients currently receiving counseling or those with unstable psychiatric medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and personalized treatment options for patients struggling with anxiety and alcohol use disorders.
How similar studies have performed: Other studies have shown promise in using personalized approaches for treating anxiety and alcohol use disorders, indicating potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Access to a smart phone * Between 18 and 65 years * Clinically significant anxiety or trauma-related symptoms * Alcohol use problems * Interest in telehealth counseling * Anticipated New Jersey or New York residence for the duration of the study Exclusion Criteria: * Currently receiving counseling * Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study) * Demonstrated indicators of more intensive or acute care * Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York
Where this trial is running
Piscataway, New Jersey
- Rutgers Robert Wood Johnson Medical School — Piscataway, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Marilyn Piccirillo, PhD — Rutgers Robert Wood Johnson Medical School
- Study coordinator: Marilyn Piccirillo, PhD
- Email: marilyn.piccirillo@rutgers.edu
- Phone: 732-235-4341
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.